Dr. Jack J. Lin, MD

Dr. Lin practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Lin's NPI, 1649383381, was assigned on August 16, 2006. Dr. Lin graduated from Rush Medical College in 1998. Dr. Lin holds California license A72100.

Dr. Lin's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Lin's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Lin to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lin is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lin's licenses on file in 2 states: California and Illinois.

Dmand AI lists epilepsy, hereditary polyneuropathy, migraine and chronic headache and vertigo among the conditions Dr. Lin treats.

CMS data shows 233 Medicare services from Dr. Lin across 7 procedure codes in 2024, for 105 Medicare patients. Medicare paid $18,993 for them.

CMS counts 105 Medicare patients who saw Dr. Lin in 2024. The largest group is under 65, with 53 patients. 61% of them have high blood pressure, and 51% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 47, with 51% women.

In 2024, Dr. Lin wrote 494 Medicare Part D claims for 47 patients. 70% of them were for generic drugs. CMS names the drug for 399 of them, across 11 drugs with 11 or more claims each, at $346,175 in total drug cost. In 2023, CMS named 284 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 111 papers to Dr. Lin, published from 2011 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Brain, Electrocorticography and Electroencephalography. Dr. Lin has published most often in Epilepsia. Dr. Lin's most frequent co-authors are Robert Thomas Knight, MD, Sumeet Vadera, MD and Lilit Mnatsakanyan, MD.

Dmand AI links Dr. Lin to 1 clinical trial. Conditions studied include Neuritis and Spinal Diseases.

CMS Open Payments shows 168 general payments to Dr. Lin from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. UCB, Inc. paid the most, $33,429.

Dmand AI lists 11 awards for Dr. Lin, most recently "Rising Star" in 2013.

Dr. Lin graduated from Rush Medical College in 1998. Dr. Lin is a member of AAN.

Dr. Lin is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.